Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.19 +0.15 (+0.60%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

MarketBeat Week in Review – 10/06 - 10/10 ↗

October 11, 2025

Investors are eagerly awaiting the start of earnings season for market direction, as the continued government shutdown is creating a lack of economic data

Via MarketBeat

Topics Economy

Government Shutdown Jitters: 2026 Social Security COLA Back on Track, Averting Further Economic Uncertainty

October 10, 2025

Washington D.C., October 10, 2025 – The highly anticipated 2026 Social Security Cost-of-Living Adjustment (COLA) announcement, a critical financial marker for nearly 74 million Americans, faced...

Via MarketMinute

Topics Economy Retirement

US Government Shutdown Rattles Global Markets, Igniting Uncertainty and Fueling Losses on October 10, 2025

October 10, 2025

The ongoing U.S. federal government shutdown, now in its tenth day as of October 10, 2025, has sent significant tremors through global financial markets. The persistent congressional deadlock over...

Via MarketMinute

Topics Bonds Economy World Trade

Inflation's Shadow Lengthens: September CPI Ignites Fed Caution Amidst Government Shutdown

October 10, 2025

Washington D.C., October 10, 2025 – The financial markets are bracing for impact as the September 2025 Consumer Price Index (CPI) report looms, a critical piece of economic data that promises to shine...

Via MarketMinute

Topics Bonds Economy World Trade

Medpace and Revvity Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

Why Hims & Hers Health (HIMS) Stock Is Nosediving

October 10, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after a Bank of America report highlighted weakening order trends and a lowered fourth-quarter revenue...

Via StockStory

Topics World Trade

Trump Plans AstraZeneca Deal To Cut Drug Prices For Low-Income Americans ↗

October 10, 2025

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing model.

Via Benzinga

Topics Government

Friday's session: most active stock in the S&P500 index ↗

October 10, 2025

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

Via Chartmill

JPMorgan Elevates Incyte Price Target Amidst Robust Pipeline and Commercial Success, Yet Maintains Cautious "Neutral" Stance

October 10, 2025

JPMorgan Chase & Co. (NYSE: JPM) has recently recalibrated its outlook on the biopharmaceutical giant Incyte Corporation (NASDAQ: INCY), with a notable upward revision of its price target for the...

Via MarketMinute

Topics Economy Intellectual Property

2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now ↗

October 10, 2025

Ongoing developments make these companies look attractive.

Via The Motley Fool

Topics Economy World Trade

Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors? ↗

October 10, 2025

A new deal with the White House could lead to a new sales channel that bypasses health insurance companies.

Via The Motley Fool

Topics Economy Government World Trade

Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation

October 09, 2025

New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Healthcare Sector Shines as a Defensive Anchor Amidst Market Volatility

October 09, 2025

In a period marked by broader market retreats and economic uncertainties, the healthcare sector is emerging as a beacon of resilience, demonstrating its enduring defensive nature. As of October 9,...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds

October 09, 2025

New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of...

Via MarketMinute

Topics Economy Intellectual Property Retirement

Pfizer Declares Fourth-Quarter 2025 Dividend

October 09, 2025

From Pfizer Inc.

Via Business Wire

Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch ↗

October 09, 2025

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

Via Benzinga

Topics Government

Most active S&P500 stocks in Thursday's session ↗

October 09, 2025

Looking for the most active stocks in the S&P500 index on Thursday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

Via Chartmill

Investors Brace for Pullback as Short-Bias ETF Inflows Signal Growing Bearishness

October 09, 2025

A significant surge in capital flowing into short-bias Exchange-Traded Funds (ETFs) has sent a clear signal through the financial markets: investor sentiment is shifting towards caution and a potential...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Why Shares in Viking Therapeutics Surged This Week ↗

October 09, 2025

The small-cap pharmaceutical company may be the next in line as takeover fever heats up.

Via The Motley Fool

Market Giants Retreat: S&P 500 and Nasdaq Pull Back from Record Highs Amidst Economic Headwinds

October 09, 2025

The relentless ascent of the U.S. stock market has hit a significant speed bump, as both the S&P 500 and Nasdaq Composite have retreated from their recent record highs. This pullback, occurring after...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Wilsey Discloses $2.9 Million Purchase of Pfizer Stock Amid Landmark Trump Deal ↗

October 09, 2025

Via The Motley Fool

Topics Government Regulatory Compliance

Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing ↗

October 09, 2025

Via The Motley Fool

Topics Government World Trade

5 Healthcare Plays Powering the Sector’s Big Comeback ↗

October 09, 2025

After years of lagging, the healthcare sector is showing signs of a turnaround driven by lower rates, policy clarity, and renewed investor interest.

Via MarketBeat

Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market ↗

October 09, 2025

Roche has a promising GLP-1 drug that is entering phase 3 trials.

Via The Motley Fool

What's going on in today's session: S&P500 most active stocks ↗

October 08, 2025

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Wednesday. Discover the stocks that are generating the highest...

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

Why Waters Corporation (WAT) Stock Is Up Today

October 08, 2025

Shares of scientific instruments company Waters Corporation (NYSE:WAT) jumped 3.2% in the morning session after Rothschild & Co initiated coverage on the stock with a 'Buy' rating and a $390 price...

Via StockStory

Topics Government

Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook

October 08, 2025

Carlsbad, CA – October 8, 2025 – Ionis Pharmaceuticals (NASDAQ:IONS) is currently witnessing a remarkable surge in its stock value, nearing a six-year high. This impressive ascent is largely driven by...

Via MarketMinute

U.S. Government Shutdown Deepens Economic Uncertainty, Airports Face Mounting Strain

October 08, 2025

Washington D.C., October 8, 2025 – The U.S. federal government remains in the throes of a shutdown, now entering its second week, as lawmakers in Washington continue to grapple with a stalemate over...

Via MarketMinute

Topics Bonds Economy Government

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Pfizer (NY:PFE)

All News about Pfizer

Starting at $3.75/week.

Subscribe Today